Skip to content

BIONOVATE TECHNOLOGIES CORP.: 10-Q filed 2021-05-17

What BIONOVATE TECHNOLOGIES CORP. reported in its quarterly report filed 2021-05-17 (fiscal Q3 2021): 22 published measures, 70 facts as tagged in accession 0001640334-21-001184.

This filing

Form
10-Q (quarterly report)
Filed
2021-05-17
Fiscal period
fiscal Q3 2021
Accession
0001640334-21-001184 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIONOVATE TECHNOLOGIES CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-03-310USD
At 2020-06-300USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-03-31483,638USD
At 2020-06-30396,665USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-03-31-483,638USD
At 2020-12-31-451,973USD
At 2020-09-30-419,539USD
At 2020-06-30-396,665USD
At 2020-03-31-375,703USD
At 2019-12-31-387,816USD
At 2019-09-30-361,139USD
At 2019-06-30-332,289USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-03-310USD
At 2020-06-300USD
At 2020-03-310USD
At 2019-06-300USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-01-01 to 2021-03-31-31,665USD90
2020-07-01 to 2021-03-31-86,973USD274
2020-10-01 to 2020-12-31-32,434USD92
2020-07-01 to 2020-09-30-22,874USD92
2020-01-01 to 2020-03-31-24,138USD91
2019-07-01 to 2020-03-31-99,083USD275
2019-10-01 to 2019-12-31-45,569USD92
2019-07-01 to 2019-09-30-29,376USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-07-01 to 2021-03-310USD274
2019-07-01 to 2020-03-310USD275

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2021-01-01 to 2021-03-310USD90
2020-07-01 to 2021-03-310USD274
2020-01-01 to 2020-03-310USD91
2019-07-01 to 2020-03-310USD275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-03-31-2,785,213USD
At 2020-06-30-2,698,240USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-03-31-16,685USD90
2020-07-01 to 2021-03-31-40,995USD274
2020-01-01 to 2020-03-31-2,748USD91
2019-07-01 to 2020-03-31-27,110USD275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-03-310USD
At 2020-06-300USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2021-01-01 to 2021-03-3115,026USD90
2020-07-01 to 2021-03-3145,742USD274
2020-01-01 to 2020-03-3121,600USD91
2019-07-01 to 2020-03-3172,076USD275

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-03-31483,638USD
At 2020-06-30396,665USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2021-03-3133,878USD
At 2020-06-3025,702USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-01-01 to 2021-03-3116,685USD90
2020-07-01 to 2021-03-3140,995USD274
2020-01-01 to 2020-03-312,748USD91
2019-07-01 to 2020-03-3127,110USD275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-03-3145,603,598shares
At 2020-06-3059,423,598shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2021-03-312,297,015USD
At 2020-06-302,295,633USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2021-03-310USD
At 2020-06-300USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2021-03-310USD
At 2020-06-3012,654USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2021-01-01 to 2021-03-310USD90
2020-07-01 to 2021-03-31850USD274
2020-01-01 to 2020-03-310USD91
2019-07-01 to 2020-03-310USD275

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2021-01-01 to 2021-03-31-14,980USD90
2020-07-01 to 2021-03-31-45,978USD274
2020-01-01 to 2020-03-31-21,390USD91
2019-07-01 to 2020-03-31-71,973USD275

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2020-07-01 to 2021-03-310USD274
2019-07-01 to 2020-03-310USD275

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2020-07-01 to 2021-03-310USD274
2019-07-01 to 2020-03-310USD275

Inspect the source

Entity
BIONOVATE TECHNOLOGIES CORP. / CIK 0001575420
Captured
SEC response SHA-256
3a7f453b16552a566daef46e9f3eab08e75589223c6b3f8546d05522bd03527a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001575420.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))